Fundraising Fox
/Companies
Sign in

Spotlight Medical

2 known investors

Find your way into Spotlight Medical

Sign up to see every warm intro you have to Spotlight Medical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Spotlight Medical team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Spotlight Medical develops AI-enabled prognostic assays for cancer risk assessment, starting with myStage Dx, a test for early-stage ER+/HER2– breast cancer that helps clinicians identify low-risk patients within high-risk clinical groups. The assay analyzes routine pathology slides using machine learning to generate personalized relapse risk scores.

AI & Machine LearningDigital HealthMedical Devices

Founders & leadership

SBSylvain Berlemont
Sylvain BerlemontCofounder & Chief Executive OfficerSylvain Berlemont is cofounder and CEO of Spotlight Medical, which develops AI-enabled prognostic assays for cancer risk assessment.
MLMarvin Lerousseau
Marvin LerousseauCofounder & Chief Scientific Officer

Investors · 2

Kurma PartnersreportedParis · $162K – $10.8M

How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us

Funding

SEC filings, press & company announcements
  • Undisclosed amountSeed FundingJul 2024 · 4 sources
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Spotlight Medical secures €6.2M for to commercialise AI-powered prognosis tests — TFNtechfundingnews.com · Jul 2024Spotlight Medical Secures €6.2M in Seed Funding to Enhance Cancer Treatment Strategies with AI-Powered Prognosis Tests - BioSpacebiospace.com · Jul 2024Spotlight Medical Raises €6.2M in Seed Fundingfinsmes.com · Jul 2024

Frequently asked questions

What does Spotlight Medical do?
Spotlight Medical develops AI-enabled prognostic assays for cancer risk assessment, starting with myStage Dx, a test for early-stage ER+/HER2– breast cancer that helps clinicians identify low-risk patients within high-risk clinical groups. The assay analyzes routine pathology slides using machine learning to generate personalized relapse risk scores.
Who founded Spotlight Medical?
Spotlight Medical was founded by Sylvain Berlemont, Marvin Lerousseau.
Who are Spotlight Medical's investors?
Spotlight Medical's investors include Heal Capital, Kurma Partners.